Metraipolis › archive › dc_aeee8d615c4f
Lithium as a disease-modifying therapy for Parkinson's disease: mechanisms, preclinical evidence, and clinical prospects — Europe PMC PMID:42170063
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42170063
- DOI
- 10.1016/j.prdoa.2026.100440
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T09:38:51.080Z
- SHA-256 of the archived text
acd64c8840af9038f2304d13b1b40f59278d20cb91645614f58745d3ebf56bfb- Stable URL of this page
https://metraipolis.com/documento/dc_aeee8d615c4f
How to cite
Lithium as a disease-modifying therapy for Parkinson's disease: mechanisms, preclinical evidence, and clinical prospects — Europe PMC PMID:42170063 — Europe PMC (en), https://europepmc.org/article/MED/42170063 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aeee8d615c4f (Metraipolis archive dc_aeee8d615c4f, sha256 acd64c8840af9038f2304d13b1b40f59278d20cb91645614f58745d3ebf56bfb)
BibTeX
@misc{dcaeee8d615c4f,
title = {Lithium as a disease-modifying therapy for Parkinson's disease: mechanisms, preclinical evidence, and clinical prospects — Europe PMC PMID:42170063},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42170063},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aeee8d615c4f; sha256 acd64c8840af9038f2304d13b1b40f59278d20cb91645614f58745d3ebf56bfb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42170063. Agents can read the archived copy with the MCP tool read_document.